Network analyses identify liver‐specific targets for treating liver diseases
Sunjae Lee(Gwangju Institute of Science and Technology), Adil Mardinoğlu(King's College London), Joshua K. Park(Icahn School of Medicine at Mount Sinai), Martina Klevstig(Sahlgrenska University Hospital), M Snyder(Stanford University), George Kunos(National Institute on Alcohol Abuse and Alcoholism), Tim Kuijpers(Science for Life Laboratory), Ulf Smith(University of Gothenburg), Mattias Bergentall(Sahlgrenska University Hospital), Jan Borén(Göteborgs Stads), Fredrik Bäckhed(Sahlgrenska University Hospital), Azadeh Harzandi(Science for Life Laboratory), Mathias Uhlén(Science for Life Laboratory), Natasha Sikanic(Science for Life Laboratory), Cheng Zhang(King's College - North Carolina), Simon J. Elsässer(Science for Life Laboratory), Brian Piening(Providence College), Bani Mukhopadhyay(National Institutes of Health), Jens Nielsen(BioInnovation Institute), Morten Grøtli(University of Gothenburg), Zhengtao Liu(Science for Life Laboratory), Sumit Deshmukh(Science for Life Laboratory), Marcus Ståhlman(University of Gothenburg), Reşat Çınar(National Institutes of Health)
Cited by 121
Related Papers
Obesity alters gut microbial ecology
|Proceedings of the National Academy of Sciences|2005|6.1k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
|European Heart Journal|2013|2.7k
Global Analysis of Protein Activities Using Proteome Chips
|Science|2001|1.9k